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Purpose:  Hyperhomocysteinemia  is  known  to  cause  degeneration  of  retinal  ganglion  cells,  but  its  influence  on
photoreceptors remains largely unknown. In particular, the role of homocysteine-thiolactone (Hcy-T)—the physiologic
metabolite of homocysteine that has been proven to be more cytotoxic than homocysteine itself—as a factor that causes
retinopathy, has not been defined. This study aimed to investigate the toxic effects of excessive Hcy-T in a mouse model.
Methods: A total of 60 six-week-old female ICR mice were used in this study. The mice were divided into 3 experimental
groups and 2 control groups. The mice in the experimental groups were subjected to intravitreal injections of Hcy-T to
reach final estimated intravitreal concentrations at 5, 25, and 200 μM, respectively. Mice without injection (blank) and
with 0.9 NaCl injections (sham injection) were used as controls. The mice with 200 μM Hcy-T were sacrificed at days 7,
15, 45, and 90 after injection and the mice with 5 or 25 μM Hcy-T were sacrificed at day 90, with the controls sacrificed
at  day  15  or  90  for  comparison.  Semi-quantitative  dot-blot  analysis  was  performed  for  confirmation  of  retinal
homocysteinylation. The mouse retinas were evaluated microscopically, with the thickness of total and specific retinal
layers determined. Immunohistochemical analysis was performed and the labeled cells were quantified to determine the
effects of excessive Hcy-T on specific retinal cells.
Results: Dose-dependent retinal homocysteinylation after Hcy-T injection was confirmed. The homocysteinylation was
localized in the outer and inner segments of photoreceptors and the ganglion cell layer (GCL). Retinal cell degenerations
were found in the GCL, inner nuclear layer, and outer nuclear layer at day 90 after 200 µM Hcy-T injection. Significant
thickness reduction was found in the total retina, outer nuclear layer, and the outer and inner segment layers. A trend of
thickness reduction was also found in the GCL and inner nuclear layer, although this was not statistically significant. The
rhodopsin+ photoreceptors and the calbindin+ horizontal cells were significantly reduced at day 15, and were nearly ablated
at day 90 after 200 μM Hcy-T injection (p<0.001 for both day 15 and day 90), which was not seen in the sham injection
controls. The Chx-10+ or the Islet-1+ bipolar cells and the Pax-6+ amacrine cells were severely misarranged at day 90, but
no significant reduction was found for both cell types. The GFAP+ Müller cells were activated at day 15, but were not
significantly increased at day 90 after the injection.
Conclusions: Excessive retinal homocysteinylation by Hcy-T, a condition of hyperhomocysteinemia, could lead to
degeneration of photoreceptors, which might lead to retinopathies associated with severe hyperhomocysteinemia or
diabetes mellitus.Received: April 1, 2011Accepted: July 14, 2011
Homocysteine (Hcy) is a sulfur-containing amino acid
derived  from  methionine  metabolism  as  an  intermediate
metabolite. Clinically, the normal range of total plasma Hcy
falls between 5 to 15 μmol/l. Patients with Hcy concentrations
greater  than  15  μmol/l  are  considered  to  have
hyperhomocysteinemia  (hHcy)  and  the  condition  is
commonly associated with diabetes mellitus [1]. In recent
Correspondence to: Bo-Yie Chen, School of Optometry, Chung Shan
Medical University, No. 110, Chien-Kuo N. Rd., Taichung 402,
Taiwan,  ROC  Phone:  +886-4-24730022  ext.  17230;  FAX:
+886-4-2324-8131; email: boychen@csmu.edu.tw
years, hHcy has been implicated in systematic hypertension,
stroke, and other cardiovascular diseases [2,3]. In the ocular
system, many lines of evidence indicated hHcy as a risk factor
in a variety of diseases, including retinal arteriosclerosis [4],
glaucoma [5,6], exudative age-related macular degeneration
[7], and macular and optic atrophy due to retinal vascular
occlusion or non-arteritic ischemic optic neuropathy [8–10].
Notably, most hHcy-induced retinopathies are indirectly
due to retinal arteriosclerosis and thrombosis. At the cellular
level, previous studies have indicated involvement of hHcy in
vascular  endothelial  damage  and  proliferation  of  vascular
smooth muscle cells [11,12]. At the molecular level, hHcy was
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1946reported to be associated with elevated lipid peroxidation,
endoplasmic reticulum stress, DNA methylation, and collagen
accumulation [13,14]. Direct Hcy attack on retina has also
been reported. Ganapathy et al. [15] used the cystathionine
beta-synthase  (cbs)  mutant  mouse  to  study  the  effects  of
endogenous homocysteine elevation on the retina. They found
an approximate sevenfold elevation of Hcy in the cbs−/− retina.
As a result of Hcy elevation, distinct alterations were observed
in the ganglion, inner plexiform, inner nuclear, and epithelial
layers in retinas of cbs−/− and 1-year-old cbs+/− mice. High
levels of Hcy were concomitantly located in these retinal
layers, particularly the ganglion cell layer (GCL), suggesting
direct attack by Hcy [15,16]. Another study by Lee et al.
[17] showed that short-term hHcy-induced oxidative stress
can activate retinal glial cells and increase VEGF expression
in the retina.
The accumulation of Hcy in human cells depends on the
activities of methionine synthase, cystathionine β-synthase,
and methionyl-tRNA synthetase. Hcy can be metabolized by
methionine synthase through its activity to convert Hcy into
methionine.  Hcy  can  also  be  converted  into  cysteine  by
cystathionine  β-synthase.  These  two  pathways  deplete
intracellular  Hcy  in  a  healthy  manner.  A  third  metabolic
pathway  for  Hcy  is  its  conversion  into  homocysteine  -
thiolactone (Hcy-T) by methionyl-tRNA synthetase, which
occurs under normal physiologic reactions in all human cell
types  investigated  [18].  Both  Hcy  and  Hcy-T  can  attack
proteins  through  either  S-homocysteinylation  or  N-
homocysteinylation [2]. S-homocysteinylation is undertaken
by Hcy through attack on the Cys-SH group of proteins, while
N-homocysteinylation  involves  acylation  of  Lys  ε-amino
group by the activated carboxyl group of Hcy-T [1,19]. Both
types of homocysteinylation will cause protein damage and
will lead to impairment of protein function [2]. As such, retinal
proteins are liable to be attacked by homocysteinylation under
the influence of hHcy. Besides, Hcy-T has been reported to
possess  stronger  cytotoxicity  and  pro-inflammatory
properties  than  Hcy  [20].  Therefore,  the  third  metabolic
pathway  for  Hcy  will  potentially  lead  to  more  severe
retinopathies. Yet, there has been no report regarding the
direct role of Hcy-T in causing retinopathies.
Another interesting, important, and unanswered question
is how hHcy can attack retina under in vivo conditions. There
has so far been no report on hHcy-induced photoreceptor
damage, although an earlier report indicated a non-detectable
electroretinogram  in  a  case  of  combined  methylmalonic
aciduria and homocystinuria [21]. Another report also showed
some  abnormalities  on  behavior  tests  assessing  visual
function in six cases of combined methylmalonic aciduria and
homocystinuria [22]. Potentially, these clinical symptoms can
be a result of damage to the photoreceptors and to the ganglion
cells, under the influence of hHcy. Yet, there has been no data
reported on this area.
In this study, we conducted intravitreal Hcy-T injections
in a mouse model to investigate the direct role of Hcy-T in
causing  retinopathies.  Following  the  injections,  Hcy-T
remained detected at day 90 in the retina in a dose-dependent
manner, suggesting occurrence of homocysteinylation. The
toxic level of intravitreal Hcy-T started at 25 μM in this mouse
model. The ganglion cell layer (GCL), inner nuclear layer
(INL), outer nuclear layer (ONL), and the outer segment and
inner  segment  (OS/IS)  of  photoreceptors  were  severely
affected. With intravitreal Hcy-T level at 200 μM, the ONL
were all eradicated at day 90 after the injection. Total retinal
thickness was reduced as compared to that of the blank or the
sham injection controls. This reduction was also observed in
the  GCL,  INL,  ONL,  and  OS/IS  layers,  respectively.
Immunohistochemical staining localized Hcy-T, mainly in the
GCL and OS/IS layers, which persisted at day 90 after the
injection. Photoreceptor and horizontal cells were the most
affected as indicated by the disappearance of their specific
markers. The bipolar, amacrine, and Müller glial cells were
all disorganized. Our results indicate that excessive Hcy-T
leads to more extensive retinal homocysteinylation than hHcy
and most retinal cells, including photoreceptors, are damaged
under the influence of excessive Hcy-T.
METHODS
Animals: A total of 60 six-week-old female ICR mice were
used in this study. The mice were purchased from National
Laboratory Animal Center (Taipei, Taiwan, ROC). The mice
weighed about 25 g on arrival and were fed ad libitum and
kept under standard conditions with a 12 h:12 h light-dark
cycle.  The  mice  were  acclimatized  and  habituated  to  the
laboratory for at least one week before the experiments. All
animal maintenance and experiment protocols were reviewed
and approved by the Animal Care and Use Committee of
Chung  Shan  Medical  University  and  were  performed  in
agreement with the Association for Research in Vision and
Ophthalmology (ARVO) Resolution on the Use of Animals
in Research.
Study  groups  and  intravitreal  homocysteine-thiolactone
injections:  Prior  to  intravitreal  injection,  the  mice  were
anesthetized  with  intraperitoneal  injections  of  sodium
pentobarbital (45 mg/kg bodyweight). Intravitreal injection
procedures and criteria were applied following the details
published by Moore [23]. Briefly, both eyes were injected
using a 5 μl Hamilton glass syringe (Hamilton Bonaduz AG,
Bonaduz, Switzerland). The injections were made posterior to
the  iris  and  into  the  vitreous  under  a  Nikon  SMZ-645
dissection  microscope  (Nikon,  Tokyo,  Japan;  Figure  1A).
Caution was taken to avoid direct contact of the needle with
the lens. The mice were injected intravitreally with either
0.9%  NaCl  (sham  injection  control)  or  Hcy-T  (Sigma-
Aldrich, St. Louis, MO) and some mice were left without
injection to serve as blank controls (Table 1). The Hcy-T was
prepared  in  0.9%  NaCl,  pH  7.4.  The  final  intravitreal
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vitreal volume at 25 μl per eye. Hcy-T was prepared in three
stock solutions of 0.25, 1.25, and 10 mM. The injection of
0.5 μl into the vitreous gave a final estimated intravitreal
concentration of 5, 25, and 200 μM, respectively. Since the
purpose  of  this  study  was  to  assess  the  consequences  of
excessive levels of Hcy-T on the retinal cells, the intravitreal
Hcy-T concentrations tested in this study were set above a
physiologic  range  or  were  equivalent  to  those  of  the
retinopathogenetic conditions [24,25].
Semi-quantitative  dot-blot  analysis  for  retinal
homocysteinylation: Dot-blot analysis was used to test the
levels of retinal homocysteinylation after intravitreal Hcy-T
injections. After the mice were euthanatized, their eyes were
extracted, followed by removal of the cornea and the lens
tissues and separation of the retinas from the eye cups. The
retinas  were  homogenized  in  radioimmunoprecipitation
(RIPA)  buffer  (Upstate  Biotechnology,  Lake  Placid,  NY)
containing  a  protease  inhibitor  cocktail  and  were  then
centrifuged at 10,000× g for 15 min at 4 °C. The supernatants
were collected and assayed for their protein levels with a Bio-
Rad Protein Assay kit (Life Science Research, Hercules, CA)
using BSA as standard. Equal aliquots (30 μg) of the retinal
proteins were applied to a 96-well dot blot apparatus (Life
Science  Research)  and  were  then  transferred  to  a
nitrocellulose  membrane  by  vacuum  filtration.  The
preparation was immersed in 10% non-fat milk for 30 min at
room temperature and was then incubated with the rabbit anti-
homocysteine  antibody  (1/1500,  cat.  ab15154;  Abcam,
Cambridge, MA) overnight at 4 °C, followed by incubation
with the peroxidase-linked antirabbit IgG antibody (1/1000;
Jackson ImmunoResearch Laboratories, Inc., West Grove,
PA) for 1 h at room temperature. After thorough washing,
chemiluminescence  was  developed  (Immobilon  Western
chemiluminescent  horseradish  peroxidase  substrate;
Millipore, Temecula, CA) and detected with a digital imaging
system (IS4000R; Kodak, New Haven, CT). Intensities of dots
stained  with  anti-homocysteine  were  determined  by
Figure 1. The preparation of intravitreal homocysteine-thiolactone (Hcy-T) injection is illustrated in A and retinal homocystinylation as
confirmed by a semi-quantitative dot-blot analysis is shown in B and C. A: In each retinal section, the thickness measurement was made at
two sites, located approximately 200 to 300 μm apart, on either side of the optic nerve. B: Dose-dependent retinal homocystinylation was
observed on day 90 after injection. C: Quantification of relative intensity (pixels) on dot-blot membranes using an arbitrary unit of retinal
homocystinylation as compared to that of the blank control. The sample size was 5 in all groups. The error bars indicate standard error of the
means (SEMs).
TABLE 1. SUMMARY OF EXPERIMENTS
Numbers Days after injection
    when   sacrificed
Number
 of mice
Final intravitreal concentrations
1 90 8 Non-injection control (Blank control)
2 15 5 0.9% NaCl
3 90 8 0.9% NaCl
4 90 8 Homocysteine thiolactone (5 μM)
5 90 8 Homocysteine thiolactone (25 μM)
6 7 5 Homocysteine thiolactone (200 μM)
7 15 5 Homocysteine thiolactone (200 μM)
8 45 5 Homocysteine thiolactone (200 μM)
9 90 8 Homocysteine thiolactone (200 μM)
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1948calibration of the total amounts of pixels using the ImageJ
image  processing  program  (National  Institute  of  Health,
Bethesda, MD). The retinal homocysteinylation levels in the
injection groups were represented as the relative amounts of
pixels compared with those of the retinas without injection
(blank controls). Six independent samples from each injection
group were determined. To ensure independent observation,
only one eye from each mouse was randomly selected for
assessment of retinal homocysteinylation.
Microscopic evaluation and quantification of thickness for
total and specific retinal layers: For microscopic evaluations,
the mice were sacrificed by cervical dislocation. One eye from
each  mouse  was  randomly  selected  and  extracted.  The
extracted eyes were fixed in 4% formalin for at least 24 h,
washed with 0.9% NaCl, and processed through ethanol and
xylene solutions. The preparations were then embedded in
paraffin, cut at 5-μm thickness, and mounted on glass slides
following  conventional  procedures  [26–28].  Hematoxylin-
Eosin stain was performed for histopathological examinations
[28,29]. The retinal tissue sections were scanned for evidence
of gross defects and were then used to measure the thickness
of the total retina, GCL, INL, ONL, and the OS/IS of the
photoreceptors. In each retinal section, the measurement of
thickness  was  made  on  two  sites,  approximately  200  to
300 μm apart, on either side of the optic nerve. The results of
these measurements were then averaged for that particular
section. For each retina analyzed, three separate eye sections
were measured by two observers without prior knowledge of
the study groups. All measurements were performed with a
Nikon  E100  microscope  (Nikon,)  equipped  with  a  digital
camera and the ImageJ image processing program (National
Institute of Health).
Immunohistochemical analysis and quantification of labeled
cells: For immunohistochemical analysis, the retinal tissue
sections were boiled in a citrate buffer (pH 6.0) for 20 min for
antigen retrieval and were then incubated, respectively, with
one  of  the  following  antibodies:  rabbit  anti-homocysteine
(1/50, cat. ab15154; Abcam); mouse anti-rhodopsin (1/400,
cat.  Ab81702;  Abcam);  mouse  anti-calbindin  (1/50,  cat.
sc-74462;  Santa  Cruz  Biotechnology,  Santa  Cruz,  CA);
mouse anti-Pax-6 antibody (1/50, cat. sc-32766; Santa Cruz
Biotechnology);  rabbit  anti-Islet-1  (1/150,  cat.  Ab20670;
Abcam); sheep anti-Chx-10 (1/150, cat. ab16141; Abcam); or
rabbit  anti-GFAP  (1/250,  cat.  2301–1;  Epitomics,
Burlingame, CA). The preparations were then incubated with
a  horseradish  peroxidase-conjugated  secondary  antibody
(1/200),  either  antimouse,  antirabbit,  or  antisheep  IgG
(Jackson  ImmunoResearch  Laboratories,  Inc.).  After
incubation,  the  preparations  were  washed  thoroughly,
incubated  in  diaminobenzidine  tetrahydrochloride  solution
for  color  detection,  and  were  counterstained  with
hematoxylin. Positively labeled cells were counted on two
sites, approximately 200 to 300 μm, apart on either side of the
optic nerve. The areas for counting were fixed at 100 μm in
width for each site. The Rhodopsin positive cells were counted
in the ONL. The calbindin positive cells were counted in the
OPL.  The  Islet-1  or  Chx-10  or  Pax-6  positive  cells  were
counted in the INL. The glial fibrillary acidic protein (GFAP)
positive cells were counted in the whole thickness of the
retina. The results of counting were then averaged for that
particular section. For each retina analyzed, three separate
sections  were  measured  by  two  observers  without  prior
knowledge of the study groups. All quantifications of labeled
cells were performed with a Nikon E100 microscope (Nikon)
equipped  with  a  digital  camera  and  the  ImageJ  image
processing program (National Institute of Health,).
Statistical analysis: All data were obtained from triple repeats
and are presented as the means±standard error of the means
(SEMs)  and  were  compared  among  groups.  The  retinal
thickness and the means of labeled retinal cells were compared
and  analyzed  by  the  Mann–Whitney  test.  All  statistical
analyses were performed using the Prism program (GraphPad
Software, San Diego, CA).
RESULTS
Retinal homocysteinylation after intravitreal homocysteine
thiolactone injection: We first tried to determine whether
intravitreal Hcy-T injection can lead to homocysteinylation in
the  retina.  Dot-blot  analysis  was  performed  using  the
supernatant of the whole retina at day 90 after the injection.
Retinal homocysteinylation was found in a dose-dependent
manner, with the highest extent of homocysteinylation found
in  the  retinas  injected  with  Hcy-T  to  reach  a  final
concentration of 200 μM (Figure 1B). Quantitative analysis
on  the  relative  density  of  dot  blots  showed  that  Hcy-T
injections  for  final  200  μM  resulted  in  approximately  a
fivefold increase in retinal homocysteinylation compared to
the sham injection controls (p<0.001; Figure 1C). The results
indicated  that  intravitreal  Hcy-T  injections  could  lead  to
retinal  homocysteinylation  and  the  doses  of  Hcy  in  the
vitreous  fluid  will  determine  the  extent  of
homocysteinylation.
Retinal degeneration and reduced thickness of total retina and
specific retinal layers after retinal homocysteinylation: With
retinal homocysteinylation confirmed after Hcy-T injections
for  final  concentrations  of  5,  25,  and  200  μM,  we  then
examined the effects after this manipulation. There was no
evidence  of  the  degeneration  of  specific  retinal  layers
following  Hcy-T  injection  for  5  μM.  Hcy-T  injection  for
25 μM, however, started to result in retinal cell degeneration,
particularly in the GCL, INL, and ONL, where most of the
retinal cell nuclei are located (Figure 2D). Furthermore, the
inner  plexiform  layer  (IPL)  generally  became  loosely
deployed, suggesting occurrence of edema. Notably, all of the
cells  in  the  GCL,  INL,  and  ONL  exhibited  nucleus
condensation and lost their orderly organization as a layer.
Quantitative analysis showed a trend of thickness reduction
in the total retina, with significant difference found in the
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1949group injected with 200 μM of Hcy-T, as compared to that of
the sham injection control group (Figure 2F). With Hcy-T
injection,  the  GCL  and  INL  layers  were  also  reduced  in
thickness,  although  the  results  were  not  statistically
significant (Figure 2G,H). In contrast, the thickness of the
ONL and OS/IS layers were already significantly reduced
after Hcy-T injection for 25 μM, and Hcy-T injection for
200 μM lead to additional reduction (both p<0.001; Figure
2I,L). These results indicated that Hcy-T injections caused
reduction of total retinal thickness, which was likely due to
the effects on multiple retinal layers.
Localization  of  retinal  homocysteinylation  after  Hcy-T
injection: To further understand the effects of excessive Hcy-
T  on  the  retina,  we  compared  the  localization  of  retinal
homocysteinylation by immunohistochemistry at days 7, 15,
45,  and  90  after  injections  for  a  final  intravitreal  Hcy-T
concentration  at  200  μM.  Generally,  the  sites  of  retinal
homocysteinylation were most evident in the OS/IS and the
GCL layers (Figure 3C-F), as compared to the absence of
evident  localization  in  the  blank  and  the  sham  injection
controls  (Figure  3A,B).  Evidence  of  accumulation  of  the
wreckage of degenerated photoreceptors was seen on day 45
and day 90 after Hcy-T injection (Figure 3E-F).
The effect of intravitreal Hcy-T injections on specific retinal
cell types: Since the thickness reduction was observed in
multiple layers of the retina, it is important to identify the
specific retinal cell types affected after intravitreal Hcy-T
injection  for  200  μM.  We  therefore  conducted
immunohistochemistry  using  specific  markers  for
photoreceptors  (rhodopsin),  horizontal  (calbindin),  bipolar
(Chx-10  or  Islet-1),  amacrine  (Pax-6),  and  Müller  cells
(GFAP) at day 15 and day 90 following the injections. At day
15,  the  rhodopsin+  photoreceptor  cells  were  significantly
reduced  (Figure  4C)  as  compared  to  those  of  the  sham
injection  control  (Figure  4A).  This  reduction  of
photoreceptors was aggravated to the extent that almost all
photoreceptors  were  ablated  at  day  90  after  the  injection
(Figure 4D), which was not seen in the sham injection controls
(Figure 4B). The calbindin+ horizontal cells were also affected
at day 15 after the injection (Figure 4G) and were also totally
Figure 2. The effects of an intravitreal homocysteine-thiolactone (Hcy-T) injection on mouse retinas at day 90 after preparation. All retinas
were prepared with hematoxylin-eosin staining for histological assessment and for measurement of the thickness of specific layers. A: Blank
control without any injection. B: 0.9% NaCl sham injection control. C: Final intravitreal Hcy-T at 5 μM. D: Final intravitreal Hcy-T at 25
μM. E: Final intravitreal Hcy-T at 200 μM. F: Total retinal thickness. G: Ganglion cell layer (GCL) thickness. H: Inner nuclear layer (INL)
thickness. I: Outer nuclear layer (ONL) thickness. J: Outer and inner segments of photoreceptors (OS/IS) thickness. The sample size for total
retinal thickness was 5 in all groups. The error bars indicate standard error of the means (SEMs). Scale bar: 25 μm.
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1950ablated in most retinas at day 90 after the injection (Figure
4H), in contrast to the normal presence and deployment of
horizontal  cells  in  the  sham  injection  controls  at  day  15
(Figure 4E) and day 90 (Figure 4F), respectively. We used two
markers, Chx-10 and Islet-1, for the identification of bipolar
cells  (Figure  4I,P).  At  day  15  after  the  Hcy-T  injection,
misarrangement of bipolar cells was readily found (Figure
4K,O), which was not found in the sham injection controls
(Figure 4I,M). The same misarrangement of bipolar cells was
also observed at day 90 after the Hcy-T injection (Figure
4L,P), in contrast to the normal deployment of bipolar cells
seen in the sham injection controls at the same stage (Figure
4J,N). The Pax-6+ amacrine cells appeared normal at day 15
after  the  injection  (Figure  4S),  but  they  were  generally
misarranged at day 90 (Figure 4T), as compared to the sham
injection controls at day 15 (Figure 4Q) and day 90 (Figure
4R). The GFAP+ Müller cells were activated at day 15 after
the injection (Figure 4W), which was not found in the sham
injection controls (Figure 4U). However, the activated Müller
cells were generally not seen at day 90 after the injection
(Figure 4X), as compared to the results in the sham injection
control group (Figure 4V).
To further confirm our observations on the histological
level, we quantified specific retinal cell types according to the
expression of their markers. At day 15 after intravitreal Hcy-
T injections, the cell populations of rhodopsin+ photoreceptor
cells and calbindin+ horizontal cells were both significantly
reduced (Figure 5A,B; p<0.001 for both), as compared to
those of the sham injection controls. Significant reduction of
the  rhodopsin+  photoreceptor  cells  and  the  calbindin+
horizontal cells was also seen at day 90 (p<0.001 for both).
Ruction  of  cell  populations  was  also  observed  in  the
Chx-10+ (Figure 5C) or the Islet-1+ (Figure 5D) bipolar cells,
but not in the Pax-6+ amacrine cells (Figure 5E). Interestingly,
the GFAP+ Müller cells were significantly activated at day 15
after intravitreal Hcy-T injections, but the activation was not
seen at day 90 as there was no significant increase in the
numbers of Müller cells detected (Figure 5F). The results of
the quantification of specific cell types in the retinas after
intravitreal Hcy-T injection confirmed our observations on the
tissue level.
DISCUSSION
Hyperhomocysteinemia (hHcy) has been implicated in human
cardiovascular and neurodegenerative diseases, particularly
under diabetic conditions [2,3,16]. In recent years, many lines
of evidence have indicated high levels of Hcy in the plasma
or  vitreous  fluid  [24,25,30]  or  deficiency  of  methionine
synthase  [22]  as  risk  factors  of  clinical  retinopathies  and
disturbed  visual  functions  [24,31–33].  Hcy,  like  the
neurotransmitter amino acid glutamate, is excitotoxic when
its  plasma  concentration  is  elevated  [13,14].  Hcy-T,  the
metabolically  active  form  of  Hcy,  is  known  to  be  more
cytotoxic than Hcy itself [1,2,18,19] and increased Hcy-T
levels have been associated with severe diabetic retinopathy
[30]. In previous literature, although the neurotoxic effects of
Hcy-T and Hcy on retinal ganglion cells have been reported
[15,16,23,34,35], little is known about their toxic effect on
photoreceptors and other retinal cells. Clinically, however, a
methionine  synthase  deficiency  child  with  severe
hyperhomocysteinemia was reported to show photopic ERG
responses related to impaired photoreceptor function [36].
Earlier reports had also associated the combined conditions of
methylmalonic aciduria and homocystinuria with abnormal
electroretinograms and visual function [21,22]. Thus, in this
study, we established a mouse hyperhomocysteinemia model
to determine the effects of Hcy-T. The retinas administered
with  an  intravitreal  Hcy-T  injection  were  analyzed  and
compared with their age-matched blank controls and sham
injection controls.
Our present study leads to several important findings in
support of photoreceptor degeneration induced by excessive
Hcy-T.  First,  the  thickness  of  the  ONL  and  OS/IS  of
photoreceptors was reduced in the retinas following Hcy-T
Figure 3. The immunohistochemical localization of retinal homocystinylation sites at days 7, 15, 45, 90 after a homocysteine-thiolactone
(Hcy-T) injection to reach a final intravitreal Hcy-T concentration at 200 μM. A: Blank control without any injection. B: 0.9% NaCl sham
injection control at day 90. C: Day 7 after injection. D: Day 15 after injection. E: Day 45 after injection. F: Day 90 after injection. Scale bar:
40 μm.
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1951Figure 4. The cytotoxic effects of homocysteine-thiolactone (Hcy-T) on specific retinal cells as reflected by alterations of A-D: rhodopsin
positive photoreceptors, E-H: calbindin positive horizontal cells, I-L: Chx- 10 positive bipolar cells, M-P: Islet-1 positive bipolar cells, Q-
T: Pax-6 positive amacrine cells, and U-X: glial fibrillary acidic protein (GFAP) positive Müller cells at day 15 and day 90 following the
intravitreal injections. Abbreviations: GCLrepresents ganglion cell layer; INL represents inner nuclear layer; IPL represents inner plexiform
layer; ONL represents outer nuclear layer; OPL represents outer plexiform layer; OS/IS represents outer and inner segments of photoreceptors.
Scale bar: 45 μm.
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1952injections for final intravitreal concentrations at 25 μM and
200 μM, as compared to the age-matched 0.9%NaCl sham
injection  controls  or  the  blank  controls,  suggesting
photoreceptor cell loss in those layers. Second, the loss of
photoreceptors was further supported by specific localization
of  retinal  homocysteinylation  on  the  photoreceptor  OS/IS
Figure 5. Quantification of specific retinal cells per 100 μm length according to their specific markers. The markers were used to detect at day
90 following the intravitreal injections. A: Rhodopsin positive cells per 100 μm length in outer nuclear layer (ONL). B: Calbindin positive
cells per 100 μm length in the retina. C: Chx-10 positive cells per 100 μm length in inner nuclear layer (INL). D: Islet-1 positive cells per 100
μm length in INL. E: Pax-6 positive cells per 100 μm length in INL. F: Glial fibrillary acidic protein (GFAP) positive cells per 100 μm length
in the retina. The sample size for all markers was 5 in all groups. The error bars indicate standard error of the means (SEMs).
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1953junction at day 7 after Hcy-T injection for 200 μM (Figure
3C),  which  likely  started  to  damage  the  photoreceptors,
resulting in the accumulation of the wreckage of degenerated
photoreceptors as seen at day 45 and day 90 (Figure 3E-F).
Third, another line of evidence also showed a significant loss
of  rhodopsin+  photoreceptors  in  the  ONL  after  Hcy-T
injection for 200 μM, as compared to the age-matched 0.9%
NaCl sham injection controls (Figure 4A-D and Figure 5A).
As photoreceptors were found to be degenerated after
Hcy-T  injection,  several  important  implications  can  be
derived  from  this  study.  First,  the  integrity  of  the
photoreceptor OS/IS layer in the retina is highly critical as
vision stimuli are initially triggered when the photosensitive
proteins in the outer segment absorb photons and generate a
signal that will eventually be transmitted to the visual cortex.
Notably, the junction region of OS/IS serves as the site for
generation  of  new  outer  segment  discs,  where  newly
synthesized  rhodopsins  are  incorporated.  Clinically,  the
integrity  of  the  photoreceptor  OS/IS  layer  is  known  to
correlate with visual function and visual acuity in patients with
retinitis  pigmentosa  [37,38].  In  this  study,  we  observed
reduced thickness of the OS/IS layers (Figure 2D,E,J) and loss
of  rhodopsin  protein  incorporation  into  the  OS/IS  layers
(Figure 4C,D) at day 90 after Hcy-T injection. These effects
are likely to be directly caused by homocysteinylation, since
homocysteinylation was localized in the OS/IS layers (Figure
3C,D,F). When the OS/IS structures are targeted directly by
homocysteinylation,  the  physiologic  renewal  process  for
installment of photosensitive proteins will be disrupted. Thus,
the status of retinal homocysteinylation by Hcy-T might be
regarded as an important risk factor for poor visual acuity or
vision  loss  in  clinical  retinopathies  associated  with
hyperhomocysteinemia.  Second,  the  horizontal  cells  are
second-order  neurons  of  the  vertebrate  retina,  being
responsible for the lateral integration of signal transmission
between  photoreceptor  and  bipolar  cells.  Retinal  cone
photoreceptors have been reported to drive the horizontal cells
to express N-methyl-D-aspartate (NMDA) receptors [39,40].
It  has  also  been  reported  that  overstimulation  of  NMDA
receptors  by  excessive  glutamate  or  homocysteine  on  the
retinal ganglion cells in vitro leads the cells into a tract of rapid
death [23,34]. Thus, the loss of horizontal cells after Hcy-T
injection in vivo (Figure 4E-H and Figure 5B) might mediate
the same pathway to cell death. This hypothesis, however,
remains  to  be  confirmed.  Third,  Hcy-T  might  induce
endoplasmic  reticulum  (ER)  stress  and  cause  damage  to
photoreceptors, resulting in a reduction in ONL thickness
(Figure 2D-E,I). This induced ER stress and cell death has
been well documented in the vascular endothelial cells [41,
42]  and  lens  epithelial  cells  [43]  under  the  influence  of
excessive Hcy-T or Hcy. Previous reports have implicated ER
stress as a critical factor in retinal degeneration [44,45], but
without referring to hyperhomocysteinemia. It is likely that
the same mode of action occurs in the retina after Hcy-T
injection.
Apart from photoreceptor degeneration, significant loss
of horizontal cells (calbindin+ cells) in the OPL was also found
after Hcy-T injection for 200 μM as compared to the age-
matched 0.9% NaCl sham injection controls (Figure 4E-H and
Figure 5B). Ruction of cell populations was also observed in
the Chx-10+ (Figure 5C) or the Islet-1+ (Figure 5D) bipolar
cells. The disruption process of the horizontal cells (calbindin
+
 cells)  and  bipolar cells after Hcy-T injection seemed to differ
from that of the OS/IS photoreceptor layers. Hcy-T might
directly target the OS/IS layers since homocysteinylation was
localized there. In contrast, the disruption of the horizontal
cells and bipolar cells appeared to be due to indirect effects,
as no apparent homocysteinylation was localized within these
cells.  Functionally,  bipolar  and  horizontal  cells  act  as
interneurons to transfer information from photoreceptors to
ganglion  cells  [46].  Reduction  or  disruption  of  these
interneurons will lead to lower sensitivity to contrast and
differences in intensity, resulting in lower visual acuity [46–
48].  Therefore,  it  is  likely  that  hyperhomocysteinemia,
commonly found in patients with diabetes mellitus [1,24,25],
is a factor causing the reduced visual acuity found in diabetic
retinopathy.
Interestingly, the GFAP+ Müller cells were significantly
activated at day 15 after intravitreal Hcy-T injections, but the
activation was not seen at day 90, as no significant increase
in GFAP+ Müller cells was detected (Figure 5F). Müller cells
contain multiple functions vital to the health of other retinal
neuron  cells  [49,50].  They  may  be  involved  in  both  the
phagocytosis of neuronal debris and the maintenance of other
retinal cells. The early increase in GFAP+ Müller cells at day
15 may represent a functional response to deplete the damaged
retinal cells after Hcy-T injection. This early effort obviously
failed as the GFAP+ Müller cell population was reduced to
nearly the same level as that in the sham-injection control at
day 90. The result from this mouse model indicates the risk of
chronic hyperhomocysteinemia in a period of just 90 days.
We  conclude  that  excessive  Hcy-T  could  cause
degeneration  of  photoreceptors  in  the  mouse  retina.  Our
results support the necessity of evaluating photoreceptors and
the  OS/IS  junction  in  patients  with  severe
hyperhomocysteinemia or diabetes mellitus.
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